These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34794619)

  • 21. Discrimination of patients with type 2 myocardial infarction.
    Neumann JT; Sörensen NA; Rübsamen N; Ojeda F; Renné T; Qaderi V; Teltrop E; Kramer S; Quantius L; Zeller T; Karakas M; Blankenberg S; Westermann D
    Eur Heart J; 2017 Dec; 38(47):3514-3520. PubMed ID: 29020401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
    Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
    Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey.
    Yao H; Cottin Y; Chagué F; Maza M; Bichat F; Zeller M; Putot A
    Am Heart J; 2023 Dec; 266():86-97. PubMed ID: 37703947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.
    Vargas KG; Haller PM; Jäger B; Tscharre M; Binder RK; Mueller C; Lindahl B; Huber K
    Clin Res Cardiol; 2019 Jul; 108(7):749-762. PubMed ID: 30535801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 or Type 2 Myocardial Infarction in Patients with a History of Coronary Artery Disease: Data from the Emergency Department.
    Putot A; Jeanmichel M; Chagué F; Avondo A; Ray P; Manckoundia P; Zeller M; Cottin Y
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31810178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
    Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Characteristics, Outcomes, and Epidemiological Trends of Patients Admitted With Type 2 Myocardial Infarction.
    Rogers E; Torres C; Rao SV; Donatelle M; Beohar N
    J Soc Cardiovasc Angiogr Interv; 2022; 1(5):100395. PubMed ID: 39131460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
    White K; Kinarivala M; Scott I
    BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
    Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
    Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy.
    Reid C; Alturki A; Yan A; So D; Ko D; Tanguay JF; Bessissow A; Mehta S; Goodman S; Huynh T
    CJC Open; 2020 May; 2(3):118-128. PubMed ID: 32462125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry.
    Jogu HR; Arora S; Vaduganathan M; Qamar A; Pandey A; Chevli PA; Pansuriya TH; Ahmad MI; Dutta A; Sunkara PR; Qureshi W; Vasu S; Upadhya B; Bhatt DL; Januzzi JL; Herrington D
    Clin Cardiol; 2019 Jun; 42(6):592-604. PubMed ID: 30941774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular outcomes of type 2 myocardial infarction among COVID-19 patients: a propensity matched national study.
    Sattar Y; Taha A; Patel N; Victor V; Titus A; Aziz S; Gonuguntla K; Thyagaturu H; Atti L; Micho T; Almas T; Tarun T; Alraies MC; Balla S
    Expert Rev Cardiovasc Ther; 2023 May; 21(5):365-371. PubMed ID: 37038300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States: Insights From the National Inpatient Sample Database.
    Mhanna M; Minhas AMK; Ariss RW; Nazir S; Khan SU; Vaduganathan M; Blankstein R; Alam M; Nasir K; Virani SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101202. PubMed ID: 35398361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic obstructive pulmonary disease and the risk for myocardial infarction by type in people with HIV.
    Crothers K; Nance RM; Whitney BM; Harding BN; Heckbert SR; Budoff MJ; Mathews WC; Bamford L; Cachay ER; Eron JJ; Napravnik S; Moore RD; Keruly JC; Willig A; Burkholder G; Feinstein MJ; Saag MS; Kitahata MM; Crane HM; Delaney JAC;
    AIDS; 2023 Apr; 37(5):745-752. PubMed ID: 36728918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute versus chronic myocardial injury and long-term outcomes.
    Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
    Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.
    Drumright LN; Nance RM; Ruderman SA; Ma J; Whitney BM; Hahn A; Fredericksen RJ; Luu B; Lober WB; Moore RD; Budoff MJ; Keruly JC; Christopoulos K; Puryear S; Willig A; Cropsey K; Mathews WC; Cachay E; Bamford L; Eron JJ; Napravnik S; Mayer KH; O'Cleirigh C; Mccaul ME; Chander G; Feinstein MJ; Saag MS; Kitahata MM; Heckbert SR; Crane HM; Delaney JAC
    HIV Med; 2023 Jun; 24(6):703-715. PubMed ID: 36855253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 Myocardial Infarction in a Sub-Saharan Africa Population: Challenging the Current Concepts-Data From REACTIV.
    Yao H; Touré C; Ekou A; Sepih E; Cottin Y; Zeller M; Putot A; N'Guetta R
    J Am Heart Assoc; 2024 Jul; 13(14):e032149. PubMed ID: 38979833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Hospitalizations With Septic Shock Complicated by Types 1 and 2 Myocardial Infarction.
    Kamat IS; Nazir S; Minhas AMK; Nambi V; Kulkarni P; Musher D; Bozkurt B; Plana JC; Jneid H
    Am J Cardiol; 2022 Jul; 174():27-33. PubMed ID: 35523592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
    Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
    Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Readmissions Rates After Myocardial Infarction for Gastrointestinal Bleeding: A National Perspective.
    Gupta K; Khan A; Kumar M; Sawalha K; Abozenah M; Singhania R
    Dig Dis Sci; 2021 Mar; 66(3):751-759. PubMed ID: 32436123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.